ALSUntangled #63: ketogenic diets. Issue 1 (2nd January 2023)

• Record Type: Journal Article
• Authors: Bedlack, Richard; Barkhaus, Paul E.; Barnes, Benjamin; Beauchamp, Morgan; Bertorini, Tulio; Bromberg, Mark B.; Carter, Gregory T.; Chaudry, Vinay; Cudkowicz, Merit; Jackson, Ce; Levitsky, Gleb; Lund, Isaac; McDermott, Christopher; Novella, Steven; Olby, Natasha; Ostrow, Lyle; Pattee, Gary L.; Heiman-Patterson, Terry; Ratner, Dylan; Salmon, Kristiana; Steves, Susan; Terrelonge, Mark; Wicks, Paul; Wills, Anne-Marie
• Is Part Of: Amyotrophic lateral sclerosis and frontotemporal degeneration. Volume 24:Issue 1/2(2023)
• Page Start: 159
• Page End: 163
• Publication Date: 2023-01-02
• Subjects: Ketone -- ketogenic diet -- alsuntangled -- mitochondria -- transgenic animals -- therapy; 616.839
• DOI: 10.1080/21678421.2021.1990346
• Languages: English
• ISSNs: 2167-8421

Abstract

Abstract: ALSUntangled reviews alternative and off label treatments with a goal of helping patients make more informed decisions about them. Here we review ketogenic diets. We shows that these have plausible mechanisms, including augmenting cellular energy balance and reducing excitotoxicity, neuroinflammation and oxidative stress. We review a mouse model study, anecdotal reports and trials in ALS and other diseases. We conclude that there is yet not enough data to recommend ketogenic diets for patients with ALS, especially in light of the many side effects these can have.